Insider Cluster (2 insiders) ·Filed Jun 17, 2026

KROS

Keros Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $16K total
Actionable Insight • Neutral

Insider cluster is too small to draw a directional signal. Monitor for any material insider buying from C-suite or larger positions in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
KROS ▲ +5.26% at T+60d
NEUTRAL call ✓ call won +5.26% · α vs SPY +3.36% · entry $10.65 → $11.21
Entry anchored
Jun 17, 03:59 PM ET
via exchange tick
T+1d
+3.10%
call +3.10% · α +3.41%
$10.98
settled 4mo ago
T+5d
-2.25%
call -2.25% · α -0.59%
$10.41
settled 3mo ago
T+20d
-0.38%
call -0.38% · α -0.91%
$10.61
settled 3mo ago
T+60d
+5.26%
call +5.26% · α +3.36%
$11.21
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Two KROS directors made minor opposing trades: Bienaime purchased $10K worth of shares while Newton sold $6K. Total insider activity is $16K, less than 0.01% of the $199M market cap — trivial and lacking a clear directional signal.

Key Financial Metrics

Direction
mixed
Total Value
$15.7K
Insiders
2

Key Facts

  • Director Jean Jacques Bienaime purchased 1,000 shares at $10.19 for $10,190 on 2026-06-15.
  • Director Charles W. Newton sold 550 shares at $10.04 for $5,522 on 2026-06-11.
  • Total value of trades is ~$16K, representing ~0.008% of KROS's $199M market cap.
  • Both trades are open-market; no C-suite involvement.

Financial Impact

Trivial insider activity — total $16K across 2 directors, <0.01% of market cap. No material economic signal.

Risk Factors

  • Small sample — only 2 trades.
  • Directors may not be as informed about near-term catalysts as C-suite executives.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KROS-1781729786258
17 reports for KROS
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+5▲ +10.72%Jul 30, 2026
Filters
Rows
Reports for KROS — sortable, filterable
TypeNow
Sep 8, 2026
23d ago
8-K
NEUTRAL ★ 4/10
$11.31 $11.04▼ −2.39%▼ −2.05%$11.17 (−1.24%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$10.95 $11.23▲ +2.56%▲ +1.44%$11.17 (+2.01%)
Aug 3, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$10.25 $10.64▲ +3.80%▲ +3.90%$11.17 (+8.98%)
Aug 3, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$10.25 $10.64▲ +3.80%▲ +3.90%$11.17 (+8.98%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 6/10
$10.07 $11.15▲ +10.72%▲ +7.21%$11.17 (+10.92%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$10.14 $10.22▲ +0.79%▲ +0.31%$11.17 (+10.16%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$10.65 $10.41▼ −2.25%▼ −0.59%$11.17 (+4.88%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$10.07 $10.24▲ +1.69%▼ −0.72%$11.17 (+10.92%)
May 14, 2026
20w ago
8-K
BEARISH ★ 5/10
$10.99 $11.22▼ −2.09%▼ −2.81%$11.17 (−1.64%)
May 14, 2026
20w ago
Press Release
BEARISH ★ 6/10
$10.99 $11.22▼ −2.09%▼ −2.81%$11.17 (−1.64%)
Showing 10 of 17

US Market Status

Market Open — Closes in 3h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 17, 2026